Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FXKAK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,782
Award facts
- Contract value 100% obligated
- $32,781.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $32,781.84 delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 2.5 mg/0.5 mL pens on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitive award, which carries no set-aside designation, is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract employs firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist medication used for chronic weight management, reflecting the federal government's expanding pharmaceutical procurement needs across military healthcare systems.
As a child delivery order under AmerisourceBergen's $999,999,999 prime IDC through DLA Troop Support Medical (designated SPE2DX and running through December 2026), this award exemplifies the company's role as a critical pharmaceutical distributor supporting Defense Health Agency operations and military medical supply chains. AmerisourceBergen's comprehensive IDC vehicle enables the supply of specialty medications, brand-name and generic pharmaceuticals, vaccines, and medical devices across multiple therapeutic domains to support military healthcare programs globally. This delivery order represents a routine transactional execution within the company's established federal procurement framework for pharmaceutical products serving military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FXKAK?
SPE2DB25FXKAK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FXKAK worth?
The government has obligated $32,782 on SPE2DB25FXKAK.
Is contract SPE2DB25FXKAK an order under another contract?
Yes. SPE2DB25FXKAK is a delivery order under SPE2DB25D3006, an indefinite delivery contract.
Was contract SPE2DB25FXKAK competed?
The extent of competition for SPE2DB25FXKAK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award